|
"whang peng j"的相關文件
顯示項目 86-110 / 215 (共9頁)
<< < 1 2 3 4 5 6 7 8 9 > >>
每頁顯示[10|25|50]項目
| 國家衛生研究院 |
2013-01 |
Randomised clinical trial: Comparison of two everolimus dosing schedules in patients with advanced hepatocellular carcinoma
|
Shiah, HS;Chen, CY;Dai, CY;Hsiao, CF;Lin, YJ;Su, WC;Chang, JY;Whang-Peng, J;Lin, PW;Huang, JD;Chen, LT |
| 國立成功大學 |
2013-01 |
Randomised clinical trial: comparison of two everolimus dosing schedules in patients with advanced hepatocellular carcinoma
|
Shiah, H. -S.; Chen, C. -Y.; Dai, C. -Y.; Hsiao, C. -F.; Lin, Y. -J.; Su, W. -C.; Chang, J. -Y.; Whang-Peng, J.; Lin, P. -W.; Huang, J. -D.; Chen, L. -T. |
| 臺北醫學大學 |
2013 |
Honokiol Eliminates Human Oral Cancer Stem-Like Cells Accompanied with Suppression of Wnt/ β -Catenin Signaling and Apoptosis Induction
|
CJ, Yao;GM, Lai;CT, Yeh;MT, Lai;PH, Shih;WJ, Chao;Whang-Peng, J;SE, Chuang;TY, Lai |
| 臺北醫學大學 |
2013 |
Honokiol Eliminates Human Oral Cancer Stem-Like Cells Accompanied with Suppression of Wnt/ β -Catenin Signaling and Apoptosis Induction
|
Yao, CJ;Lai, GM;Yeh, CT;Lai, MT;Shih, PH;Chao, WJ;Whang-Peng, J;Chuang, SE;Lai, TY |
| 臺北醫學大學 |
2013 |
Honokiol Eliminates Human Oral Cancer Stem-Like Cells Accompanied with Suppression of Wnt/beta-Catenin Signaling and Apoptosis Induction
|
Yao, CJ;Lai, GM;Yeh, CT;Lai, MT;Shih, PH;Chao, WJ;Whang-Peng, J;Chuang, SE;Lai, TY. |
| 臺北醫學大學 |
2013 |
Honokiol Eliminates Human Oral Cancer Stem-Like Cells Accompanied with Suppression of Wnt/beta-Catenin Signaling and Apoptosis Induction
|
CJ, Yao;GM, Lai;CT, Yeh;MT, Lai;PH, Shih;WJ, Chao;Whang-Peng, J;SE, Chuang;TY, Lai |
| 國家衛生研究院 |
2012-10 |
Development and validation of an instrument for the measurement of Health-Related Quality of Life Based on View of Traditional Chinese Medicine Perspective
|
Chang, HH;Chie, WC;Chin, YH;Hsu, CP;Liu, TW;Whang-Peng, J |
| 國家衛生研究院 |
2012-01 |
Long-term results of a randomized, observation-controlled, phase III trial of adjuvant Interferon alfa-2b in hepatocellular carcinoma after curative resection
|
Chen, LT;Chen, MF;Li, LA;Lee, PH;Jeng, LB;Lin, DY;Wu, CC;Mok, KT;Chen, CL;Lee, WC;Chau, GY;Chen, YS;Lui, WY;Hsiao, CF;Whang-Peng, J;Chen, PJ |
| 國家衛生研究院 |
2011-12 |
Induction chemotherapy with gemcitabine, oxaliplatin, and 5-Fluorouracil/Leucovorin followed by concomitant chemoradiotherapy in patients with locally advanced pancreatic cancer: A Taiwan cooperative oncology group phase II study
|
Ch'ang, HJ;Lin, YL;Wang, HP;Chiu, YF;Chang, MC;Hsu, CH;Tien, YW;Chen, JS;Hsieh, RK;Lin, PW;Shan, YS;Cheng, AL;Chang, JY;Whang-Peng, J;Hwang, TL;Chen, LT |
| 國家衛生研究院 |
2011-08-17 |
A phase II and pharmacokinetic study of first line S-1 for advanced gastric cancer in Taiwan
|
Chen, JS;Chao, Y;Hsieh, RK;Cheng, AL;Chen, PM;Chiou, TJ;Chao, TY;Yeh, KH;Chen, LT;Whang-Peng, J |
| 高雄醫學大學 |
2011 |
A phase II and pharmacokinetic study of first line S-1 for advanced gastric cancer in Taiwan.
|
趙毅;鄭安理;陳立宗;彭汪嘉康 ; Chen JS;Chao Y;Hsieh RK;Cheng AL;Chen PM;Chiou TJ;Chao TY;Yeh KH;Chen LT;Whang-Peng J. |
| 國家衛生研究院 |
2010-06 |
Randomized, phase 1 study of everolimus in patients with advanced hepatocellular carcinoma
|
Shiah, H;Chen, C;Lin, Y;Su, W;Winkler, R;Chang, J;Lin, P;Whang-Peng, J;Chen, L |
| 國家衛生研究院 |
2009-12 |
Alpha-fetoprotein response in advanced hepatocellular carcinoma receiving cytostatic agent
|
Chen, LT;Shiah, HS;Chao, Y;Chang, JY;Cheng, LT;Whang-Peng, J |
| 國家衛生研究院 |
2009-11 |
Phase II study of biweekly gemcitabine followed by oxaliplatin and simplified 48-h infusion of 5-fluorouracil/leucovorin (GOFL) in advanced pancreatic cancer
|
Ch'ang, HJ;Huang, CL;Wang, HP;Shiah, HS;Chang, MC;Jan, CM;Chen, JS;Tien, YW;Hwang, TL;Lin, JT;Cheng, AL;Whang-Peng, J;Chen, LT |
| 國立臺灣大學 |
2009-11 |
Phase II study of biweekly gemcitabine followed by oxaliplatin and simplified 48-h infusion of 5-fluorouracil/leucovorin (GOFL) in advanced pancreatic cancer. Cancer Chemother Pharmacol.
|
Chang, HJ; Huang, CL; Wang, HP; Shiah, HS; Chang, MC; Jan, CM; Chen, JS; Tien, YW; Hwang, TL; Lin, JT; Cheng, AL; Whang-Peng, J; Chen, LT. |
| 國家衛生研究院 |
2009-05-20 |
Phase II randomized trial of erlotinib versus vinorelbine in chemotherapy-naive patients with advanced non-small-cell lung cancer (NSCLC) aged >= 70 years in Taiwan
|
Chen, Y;Tsai, C;Shih, J;Perng, R;Whang-Peng, J |
| 國家衛生研究院 |
2008-08 |
A phase II randomized study of vinorelbine alone or with cisplatin against chemo-naive inoperable non-small cell lung cancer in the elderly
|
Chen, YM;Perng, RP;Shih, JF;Whang-Peng, J |
| 國家衛生研究院 |
2008-07 |
Diagnostic and therapeutic evaluation of In-111-vinorelbine-liposomes in a human colorectal carcinoma HT-29/luc-bearing animal model
|
Chow, TH; Lin, YY; Hwang, JJ; Wang, HE; Tseng, YL; Pang, VF; Wang, SJ; Whang-Peng, J; Ting, G |
| 國家衛生研究院 |
2008-06 |
Chemotherapy with etoposide, doxorubicin, cisplatin, 5-fluorouracil, and leucovorin for patients with advanced hepatocellular carcinoma
|
Yuan, JN; Chao, Y; Lee, WP; Li, CP; Lee, RC; Chang, FY; Yen, SH; Lee, SD; Whang-Peng, J |
| 國家衛生研究院 |
2008-01-08 |
Quality of life after curative gastrectomy for gastric cancer in a randomised controlled trial
|
Wu, CW; Chiou, JM; Ko, FS; Lo, SS; Chen, JH; Lui, WY; Whang-Peng, J |
| 國家衛生研究院 |
2008-01 |
Phase II randomized study of weekly docetaxel alone or plus UFUR treatment in non-small cell lung cancer patients who failed previous chemotherapy
|
Chou, KT; Chen, YM; Shih, JF; Perng, RP; Tsai, CM; Whang-Peng, J |
| 國家衛生研究院 |
2007-09 |
Chromosomal aberrations of malignant pleural effusions of lung adenocarcinoma: Different cytogenetic changes are correlated with genders and smoking habits
|
Yen, CC; Liang, SC; Jong, YJ; Chen, YJ; Lin, CH; Chen, YM; Wu, YC; Su, WC; Huang, CYF; Tseng, SW; Whang-Peng, J |
| 國家衛生研究院 |
2007-06-01 |
Selection of DDX5 as a novel internal control for Q-RT-PCR from microarray data using a block bootstrap re-sampling scheme
|
Su, LJ; Chang, CW; Wu, YC; Chen, KC; Lin, CJ; Liang, SC; Lin, CH; Whang-Peng, J; Hsu, SL; Chen, CH; Huang, CYF |
| 國家衛生研究院 |
2007-06 |
A randomized phase II study of docetaxel or vinorelbine in combination with cisplatin against inoperable, chemo-naive non-small-cell lung cancer in Taiwan
|
Chen, YM; Perng, RP; Shih, JF; Tsai, CM; Whang-Peng, J |
| 國家衛生研究院 |
2007-05 |
Phase II randomized study of daily gefitinib treatment alone or with vinorelbine every 2 weeks in patients with adenocarcinoma of the lung who failed at least 2 regimens of chemotherapy
|
Chen, YM;Liu, JM;Chou, TY;Perng, RP;Tsai, CM;Whang-Peng, J |
顯示項目 86-110 / 215 (共9頁)
<< < 1 2 3 4 5 6 7 8 9 > >>
每頁顯示[10|25|50]項目
|
